HOME >> BIOLOGY >> NEWS
Millennium Clones Diet-Induced Obesity Gene

CAMBRIDGE, Mass. March 11, 1999 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) has cloned the first gene that can suppress diet-induced obesity in mice. The gene may have strong implications in developing therapies to intervene in human obesity, the authors note in their report, which appears in the March 11, 1999 issue of Nature.

The scientists found that while the gene, called mahogany (mg), produces a protein (MG) in many tissues of the body, its activity in a specific region of the brain's hypothalamus is particularly interesting because of that region's role in body weight regulation.

"The cloning of the mahogany gene and the identification of its protein product are major first steps in achieving a better understanding of their roles in controlling weight based on the amount of fat in a diet," said Karen Moore, Ph.D., director of genetic systems at Millennium. Because of the great similarity between mouse and human metabolism, the scientists expect to find that the gene plays a similar role in people.

Mice with a mutation in their mg gene maintain a healthy weight whether they eat a high fat (42 percent fat) or low fat (9 percent fat) diet with the same amount of calories. In contrast, mice with a normal mg gene gain excess weight on the high fat diet. Such diet-induced obesity differs from forms of genetically-induced obesity in which weight gain occurs even when mice are fed a normal diet. Genetically induced obesity in mice has been linked to mutations in the obese (ob), diabetes (db), tubby (tub), fat (fat) and agouti-yellow (Ay) genes. Mice with a mutation in their mg gene can suppress the genetic induced obesity of agouti-yellow mice but not that of ob, db, tub and fat mice.

The structure of the large MG protein is complex and can occur in two major forms. One form spans the cell wall leaving multiple sections of the protein to project outside the cell, which may function as receptors to which small proteins called peptide
'"/>

Contact: Marion E. Glick
m.glick@noonanrusso.com
212-696-4455 x221
Noonan/Russo Communications
11-Mar-1999


Page: 1 2 3 4

Related biology news :

1. Millenniums LDP(PS)-341 inhibits growth and induces death of cancer cells, appears to overcome chemotherapy resistance
2. Millennium and Bayer industrializing drug discovery process through ongoing successful research alliance
3. Science and Technology at the Millennium: Retrospect or Prospect Focus of AAAS Science and Technology Colloquium, April 11-13 in Washington, DC
4. Millennium and Wyeth-Ayerst announce the discovery of key potassium ion channel modulating proteins
5. Millennium and the Whitehead Institute identify novel protein important in fat absorption
6. Allelix Clones Receptor For Intestinal Growth Factor GLP-2
7. International Research Team Clones New Skin Cancer Gene
8. Obesity and hypertension: Two epidemics or one?
9. Obesity alone not a good predictor of cardiovascular risk and death, fat distribution proved best
10. Obesity drug inhibits prostate tumor growth
11. Obesity and blood pressure

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Millennium Clones Diet Induced Obesity Gene

(Date:5/24/2013)... 24, 2013 A frequently expressed concern in the ongoing ... fresh vegetables, especially those that are nutrient dense. ... and Beans Provide Most Nutrients Per Penny," published in ... are one of the best nutritional values in the ... per penny than most other raw vegetables and delivering ...
(Date:5/24/2013)... detection and destruction by the immune system. Stimulation of ... however, there are many factors that cause the immune ... immune cells that function to suppress the immune system ... Clinical Investigation , researchers led by Ronald Levy at ... tumors express proteins that can be targeted with therapeutic ...
(Date:5/24/2013)... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ... Alessia Soldano (VIB/KU Leuven): "We have discovered that APPL ensures ...
Breaking Biology News(10 mins):New research shows that potatoes provide one of the best nutritional values per penny 2A new strategy required in the search for Alzheimer's drugs? 2
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan ... human cord blood stem cell banking and therapeutics, announced ... the No. 16 Acorn Stairlifts Indy car driven by ... the remainder of the IZOD IndyCar 2013 season.   ... will work to support awareness of umbilical cord blood ...
(Date:5/23/2013)... Calif. , May 23, 2013 ... a strategic alliance with DAK Renewable Research to ... corn oil yield. VG Energy is a majority ... Pink: VGLS). VG Energy,s exclusively licensed ... increase the oil yield in plants, possessing a ...
(Date:5/23/2013)... , May 23, 2013 BioTrends Research ... advisory firms for specialized biopharmaceutical issues, finds that, ... infectious disease specialists reported that in the past ... intentionally delaying treatment) in anticipation of the next ... months ago, when only 6 percent reported that ...
(Date:5/23/2013)... 23, 2013 Northwest Biotherapeutics (NASDAQ: ... ® personalized immune therapies for solid tumor cancers, ... this year,s American Society Of Clinical Oncology (ASCO) meeting ... leadership role in immune therapy.  (Logo: ... is the pre-eminent conference focused on clinical treatment of ...
Breaking Biology Technology:StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: